This Pharma Exec Has A New Treatment To Extend Life, Plus A Possible Landmark Weight-Loss Drug

James Peyer is the CEO and Founder of Cambrian. Peyer's goal with his pharma-bio company is to create healthier drugs that lengthen lifespans and improve overall health in individuals. Peyer was previously Managing Partner with Apollo Ventures, the first global longevity-focused venture capital firm. He is a graduate of UT Southwestern (National Science Foundation Fellow) with a PhD in blood and stem cell biology.

James and Diane Brady speak at Founder's Forum about Cambrian's newest business developments, timelines of producing Cambrian's products and how a healthier lifestyle holds as much influence as good medicine.